Significance of pentraxin-3 in patients with juvenile scleroderma

Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):221-222. Epub 2017 Jun 20.

Authors

Amra Adrovic¹, Sezgin Sahin¹, Kenan Barut¹, Sinem Durmus², Hafize Uzun², Ozgur Kasapcopur³

Affiliations

¹ Istanbul University, Cerrahpasa Medical School, Department of Paediatric Rheumatology, Istanbul, Turkey.
² Istanbul University, Cerrahpasa Medical School, Department of Biochemistry, Istanbul, Turkey.
³ Istanbul University, Cerrahpasa Medical School, Department of Paediatric Rheumatology, Istanbul, Turkey. ozgurkasapcopur@hotmail.com.

PMID: 28664833

No abstract available

MeSH terms

Adolescent
C-Reactive Protein / analysis*
Child
Female
Humans
Male
Scleroderma, Localized / blood*
Scleroderma, Systemic / blood*
Serum Amyloid P-Component / analysis*

Substances

Serum Amyloid P-Component
PTX3 protein
C-Reactive Protein

Supplementary concepts

Juvenile-onset scleroderma